Ophthalmology Research and Drug Development | Charles River

ophthalmology 

 
 

With the expected changes in demographics over the next 10-15 years, there is a growing need to increase and accelerate the development of safe and effective therapies for eye disorders. Charles River has the necessary understanding of eye-related diseases and conditions as well as the technical ability and experience to guide your new drugs and treatments through the development process as efficiently as possible. 

Through our Preclinical, Clinical, and Research Models products and services groups, we offer you an integrated approach to ophthalmology research. Compounds or implantable devices intended for ocular treatment can be assessed for efficacy, safety, and toxicity. In addition, ocular effects of compounds targeted to non-ocular conditions can also be characterized. 

Discover the full range of Charles River Products and Services

For more information please call:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Mar 01 - New Technical Resources Section Av...
Jan 11 - Charles River to Suspend Operation...
Mar 22-Mar 23 - San Francisco, CA - 2010 PMF Bacterial Endotoxin Summit
Mar 15-Mar 19 - Orlando, FL - 2010 PDA Annual Meeting
May 05-May 05 - Tempe, AZ - Rodent Colony and Disease Management Considerations – A Sem...
view all
Corporate Sr. VP, Corporate Development 
Corporate VP, Corporate Tax Wilmington, M...

Charles River Laboratories, Inc.